Is SPRC or SRPT more undervalued in 2026?

CirclFi compares SciSparc Ltd. (SPRC) and Sarepta Therapeutics, Inc. (SRPT) using 13 institutional-grade valuation models. SPRC has a Quality of Company score of 1.7/10 while SRPT scores 7.5/10.

Which is a better buy — SPRC or SRPT?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do SPRC and SRPT valuations compare?

SPRC at $9.81 and SRPT at $17.87 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

SPRC vs SRPT Valuation Comparison 2026 — Intrinsic Value Analysis

SPRC

Pharmaceutical Preparations

SciSparc Ltd.

Quality

1.7

out of 10

Value Trap

—

Price

$9.81

Last close

Models

5/13

Active

SRPT

Pharmaceutical Preparations

Sarepta Therapeutics, Inc.

Quality

7.5

out of 10

Value Trap

SAFE

Price

$17.87

Last close

Models

13/13

Active

Model-by-Model Comparison

Model	Type	SPRC Fair Value	SPRC Upside	SRPT Fair Value	SRPT Upside
Bayesian DCF	Intrinsic	$1.09	-88.9%	$1.07	-94.0%
Earnings Power Value	Intrinsic	—	—	$4.59	-77.4%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$5.10	+24.5%	$34.02	+90.4%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for SPRC vs SRPT — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

SPRC vs SRPT — Which Stock Is More Undervalued?

SRPT scores higher with a 7.5/10 quality rating vs SPRC's 1.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing SciSparc Ltd. (SPRC) and Sarepta Therapeutics, Inc. (SRPT) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

SPRC currently trades at $9.81 with a QOC of 1.7/10, while SRPT trades at $17.87 with a QOC of 7.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).